LBI-HTA - Publications - Search - Advanced Therapy Medicinal Products (ATMPs): Technology forecast

Eder, C. and Wild, C. (2019): Advanced Therapy Medicinal Products (ATMPs): Technology forecast. Journal of Market Access & Health Policy 7 (1).

Full text not available from this repository.

Official URL: https://www.tandfonline.com/doi/full/10.1080/20016689.2019.1600939

Abstract

"Advanced Therapy Medicinal Products" (ATMPs) is the umbrella term for three classes of medicinal products: somatic cell therapy medicinal products, gene therapy medicinal products and biotechnologically processed tissue preparations [also known as tissue engineering products (TEP)], as well as combination products. These drugs contain -or mostly consist of- living cells or tissues and are therefore highly complex. The cells used are often taken from a patient, processed in the laboratory (e.g. increased or genetically modified) and then administered again to the same patient.

The review of the LBI-HTA (published only as an English publication, not as a report) gives an overview of applications of ATMP products shortly before or after their market launch.

Item Type:Article
Keywords:ATMP, Advanced Therapy Medicinal Products, Cell therapy, Tissue Engineering, gene therapy
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QT Physiology > QT 34-37 Physics. Mathematics. Engineering > QT 36-37 Biomedical engineering, nanotechnology, biocompatible materials
QU Biochemistry > QU 300-375 Cells
Language:English
Number:1
Deposited on:29 Apr 2019 12:09
Last Modified:02 May 2019 12:39

Repository Staff Only: item control page